---
figid: PMC3317177__JO2012-382159.001
figlink: /pmc/articles/PMC3317177/figure/fig1/
number: F1
caption: New therapeutic approaches based on targeted biologic agents have generated
  great interest and are currently being investigated in several clinical trials focused
  on treatments for recurrent ovarian cancer (). As is the case for other cancers,
  angiogenesis is a key process implicated in the metastatization of ovarian cancer.
  Several growth factors, including vascular endothelial growth factor A (VEGFA),
  lysophosphatidic acid (LPA), interleukin 6 (IL6), interleukin 8 (IL8), and fibroblast
  growth factor 1 (FGF1) and 2 (FGF2) are involved in this process [, ]. To date,
  agents that target the VEGF pathway have proven the most effective against the disease.
pmcid: PMC3317177
papertitle: 'Special Agents Hunting Down Women Silent Killer: The Emerging Role of
  the p38Î± Kinase.'
reftext: Valentina Grossi, et al. J Oncol. 2012;2012:382159.
pmc_ranked_result_index: '46971'
pathway_score: 0.7917757
filename: JO2012-382159.001.jpg
figtitle: New therapeutic approaches based on targeted biologic agents have generated
  great interest and are currently being investigated in several clinical trials focused
  on treatments for recurrent ovarian cancer ()
year: '2012'
organisms: Homo sapiens
ndex: be24026f-df2b-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3317177__JO2012-382159.001.html
  '@type': Dataset
  description: New therapeutic approaches based on targeted biologic agents have generated
    great interest and are currently being investigated in several clinical trials
    focused on treatments for recurrent ovarian cancer (). As is the case for other
    cancers, angiogenesis is a key process implicated in the metastatization of ovarian
    cancer. Several growth factors, including vascular endothelial growth factor A
    (VEGFA), lysophosphatidic acid (LPA), interleukin 6 (IL6), interleukin 8 (IL8),
    and fibroblast growth factor 1 (FGF1) and 2 (FGF2) are involved in this process
    [, ]. To date, agents that target the VEGF pathway have proven the most effective
    against the disease.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LDHA
  - PARP9
  - TNKS2
  - PRKAB2
  - PRKAG3
  - PRKAG2
  - PARP3
  - PARP12
  - A4GALT
  - PRKAG1
  - AKT1
  - PRKAA1
  - CYP19A1
  - PARP11
  - PRKAA2
  - PARP1
  - PARP8
  - PARP4
  - PARP15
  - MFAP1
  - EGFR
  - PARP6
  - PRKAB1
  - PARP10
  - PARP2
  - PARP14
  - TNKS
  - AKT2
  - PARP16
  - ERBB2
  - TIPARP
  - AKT3
  - SB202190
  - perifosine
  - Cediranib
  - Cisplatin
  - Carboplatin
  - Paclitaxel
genes:
- word: LDHA
  symbol: LDHA
  source: hgnc_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PK
  symbol: P(k)
  source: hgnc_alias_symbol
  hgnc_symbol: A4GALT
  entrez: '53947'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: PIJK/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: Aromatase
  symbol: aromatase
  source: hgnc_alias_symbol
  hgnc_symbol: CYP19A1
  entrez: '1588'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: PIJK/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: HER-2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: PIJK/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
chemicals:
- word: SB202190
  source: MESH
  identifier: C090942
- word: perifosine
  source: MESH
  identifier: C105905
- word: Cediranib
  source: MESH
  identifier: C500926
- word: Cisplatin
  source: MESH
  identifier: D002945
- word: Carboplatin
  source: MESH
  identifier: D016190
- word: Paclitaxel
  source: MESH
  identifier: D017239
diseases: []
figid_alias: PMC3317177__F1
redirect_from: /figures/PMC3317177__F1
figtype: Figure
---
